People: BioScrip Inc (BIOS.O)

BIOS.O on Nasdaq

6.12USD
19 Dec 2014
Price Change (% chg)

$-0.04 (-0.57%)
Prev Close
$6.16
Open
$6.14
Day's High
$6.21
Day's Low
$5.98
Volume
1,639,991
Avg. Vol
1,054,547
52-wk High
$9.05
52-wk Low
$5.44

Search Stocks

Summary

Name Age Since Current Position

Myron Holubiak

74 2012 Independent Chairman of the Board

Richard Smith

54 2013 President, Chief Executive Officer, Director

Hai Tran

44 2012 Chief Financial Officer, Treasurer

Thomas Pettit

45 2014 Chief Operating Officer, Senior Vice President

Brian Stiver

51 2012 Senior Vice President - National Infusion Sales

Vito Ponzio

59 2010 Senior Vice President - Human Resources

David Evans

50 2009 Senior Vice President - Strategic Operations

Barbara Cormier

71 2012 Chief Compliance Officer and Privacy Officer

Patricia Bogusz

54 2011 Vice President - Finance, Principal Accounting Officer

Daniel Colucci

49 2011 Vice President - PBM Services

Charlotte Collins

61 2003 Independent Director

Samuel Frieder

50 2010 Independent Director

David Hubers

71 2005 Independent Director

Yon Jorden

59 2014 Independent Director

Huong Thi Nguyen

41 2014 Independent Director

Stuart Samuels

72 2005 Independent Director

Gordon Woodward

45 2010 Independent Director

Lisa Carlton-Wilson

President

Biographies

Name Description

Myron Holubiak

Mr. Myron Z. Holubiak is an Independent Chairman of the Board of BioScrip Inc. Mr. Holubiak joined the Company as its President and Chief Operating Officer in January 2009 and was appointed a director of the Company in September 2009. On January 1, 2011, Mr. Smith became the Company’s Chief Executive Officer. Prior to joining the Company, from June 2006 to December 2008, Mr. Smith was Chief Executive Officer and a director of Byram Healthcare Centers, Inc., a provider of medical supplies and pharmacy items to long-term chronic patients. From May 2003 to May 2006, Mr. Smith was the President and Chief Operating Officer of Option Care, Inc., a home infusion and specialty pharmaceutical company. We believe his experience in the healthcare and home infusion industries and managerial background, together with his specific past experience as a Chief Executive Officer, are particularly relevant to Mr. Smith’s service on the Board. Further, as the only Board member who is also a member of the Company’s management team, Mr. Smith provides management’s perspective in Board discussions about the operations and strategic direction of the Company.

Richard Smith

Mr. Richard M. Smith is President, Chief Executive Officer, Director of BioScrip Inc. Mr. Smith joined the Company as its President and Chief Operating Officer in January 2009 and was appointed a director of the Company in September 2009. On January 1, 2011, Mr. Smith became the Company’s Chief Executive Officer. Prior to joining the Company, from June 2006 to December 2008, Mr. Smith was Chief Executive Officer and a director of Byram Healthcare Centers, Inc., a provider of medical supplies and pharmacy items to long-term chronic patients. From May 2003 to May 2006, Mr. Smith was the President and Chief Operating Officer of Option Care, Inc., a home infusion and specialty pharmaceutical company. We believe his experience in the healthcare and home infusion industries and managerial background, together with his specific past experience as a Chief Executive Officer, are particularly relevant to Mr. Smith’s service on the Board. Further, as the only Board member who is also a member of the Company’s management team, Mr. Smith provides management’s perspective in Board discussions about the operations and strategic direction of the Company.

Hai Tran

Mr. Hai V. Tran serves as Chief Financial Officer, Treasurer of BioScrip Inc. Mr. Tran was the Chief Financial Officer and VP International of Harris Healthcare Solutions, a subsidiary of Harris Corporation, a diversified technology company, from 2011 to May 2012. From 2008 to 2011, Mr. Tran served as Chief Financial Officer of Catalyst Health Solutions, Inc., a pharmacy benefit management company. Mr. Tran served as Vice President and Treasurer of Hanger Orthopedic Group, a healthcare services, products, and distribution company, from 2006 to May 2008. Mr. Tran holds a bachelor’s degree in electrical engineering from the University of Virginia and a master’s degree in business administration from the University of Richmond.

Thomas Pettit

Mr. Thomas F. Pettit serves as Chief Operating Officer, Senior Vice President of BIOSCRIP, INC. Mr. Pettit most recently served from early 2013 to mid-2014 as Senior Vice President and General Manager of the Supply Chain Solutions business segment of Ryder System, Inc., a logistics and distribution services provider with annual revenue in excess of $1 billion. While at Ryder, Mr. Pettit helped to grow revenues and profits, while also expanding margins through lean process improvements. From 2008 to 2013, he served as Vice President of Global Operations at Pentair, Inc., a commercial and residential water products and services company, during which he developed and executed the Company's global operations footprint strategy, strengthened supply chain management, and improved customer and shareholder results through lean initiatives. Prior to joining Pentair, Mr. Pettit held senior-level operations positions at ADC Telecommunications, Inc. and General Electric Company. Previously he served as a general management consultant at McKinsey & Company Inc. and Towers Perrin, where he developed post-merger integration and marketing strategies. Mr. Pettit began his career with service in the U.S. Army Corps of Engineers as both a Company Executive Officer and a Construction Platoon Leader. Mr. Pettit holds a bachelor's of science degree in economics from the United States Military Academy at West Point and a master's degree in business administration from the University of Hawaii.

Brian Stiver

Mr. Brian Stiver is Senior Vice President - National Infusion Sales of BioScrip Inc. Mr. Stiver joined the Company in March 2009 as Vice President of Sales and was appointed Senior Vice President of Sales in July 2012. Mr. Stiver was Vice President Specialty Pharmacy at Walgreen Co. from November 2007 to March 2009, and was Vice President of Business Development for OptionCare from January 2003 through October 2007, prior to the acquisition of OptionCare by Walgreens.

Vito Ponzio

Mr. Vito Ponzio, Jr., is Senior Vice President - Human Resources of BioScrip Inc. Mr. Ponzio was appointed Senior Vice President of Human Resources on December 2010. Mr. Ponzio joined BioScrip in January 2010 and was responsible for all operations aspects of the Community Store Division. Previously, Mr. Ponzio was the Senior Vice President, Administration for Coram Specialty Infusion Services (“Coram”), a division of Apria Healthcare. He was with Coram for 19 years, from 1990 to 2009, and was responsible for human resources, legal, risk management, facilities and construction management, clinical operations and payroll. During his tenure, he also held the position of Compliance Officer and EEO Officer of Coram and served on the Board of Directors for all Coram subsidiary companies.

David Evans

Mr. David Evans is Senior Vice President - Strategic Operations of BioScrip Inc. Mr. Evans has been in the health care provider arena for 24 years. Mr. Evans joined BioScrip in February 2009. Prior to joining BioScrip, from August 2006 to July 2008, Mr. Evans was Chief Financial Officer and Secretary of Byram Healthcare Centers, Inc., a provider of medical supplies and pharmacy items to long term chronic patients, departing after the sale of the Company to Mediq, formerly named OPG Groep NV. From June 2003 to August 2006, Mr. Evans was the Corporate Vice President, Strategic Operations of Option Care, Inc., a home infusion and specialty pharmaceutical company.

Barbara Cormier

Ms. Barbara Cormier is Chief Compliance Officer and Privacy Officer of BioScrip Inc. Ms. Cormier joined BioScrip in March 2000 as the Vice President of Pharmaceutical Relations, she was appointed Chief Compliance Officer in 2003 and she was appointed Privacy Officer in 2012.

Patricia Bogusz

Ms. Patricia Bogusz is Vice President - Finance, Principal Accounting Officer of BioScrip Inc. Ms. Bogusz was Vice President and Controller from July, 2007 to April, 2011. Prior to joining BioScrip, Ms. Bogusz served in various divisional controller, customer quality assurance and internal audit positions at Carlson Companies, The Valspar Corporation, and Burlington Northern Santé Fe Corporation.

Daniel Colucci

Mr. Daniel Colucci is Vice President - PBM Services of BioScrip Inc. He joined BioScrip in 2001 and has served as Vice President of PBM Services for BioScrip since April of 2005. Dan manages BioScrip’s PBM Services division. Dan previously served as Vice President, Provider Affairs for Scrip Solutions, LLC (a BioScrip predecessor company), effective July 2002. Prior to that he was Director of Sales and Marketing Operations for Scrip Solutions. Previous to BioScrip, Dan worked for PharmaCare Management Services as Sales Director and Manager of Market Development and for ValueRx as Director of Client Research and Director of Marketing Research.

Charlotte Collins

Ms. Charlotte W. Collins, Esq., is an Independent Director of BioScrip Inc., since April 2003. Since January 2008, she has been a senior executive in charge of policy for the Asthma and Allergy Foundation of America (the “Foundation”). Since 2010, Ms. Collins has also been in charge of education programs for the Foundation and is currently its Senior Vice President for Policy and Programs. From 2003 to 2007, she was Associate Professor of Health Services Management and Leadership, and Health Policy at the George Washington University School of Public Health and Health Services. From January 2002 to June 2003, she was an Associate Research Professor of Health Policy at the same university. She served a four year term on the National Allergy and Infectious Diseases Advisory Council of the National Institutes of Health beginning in 2001. From September 1996 to November 2004, Ms. Collins was Of Counsel in the health policy practice of the law firm of Powell, Goldstein LLP in its Washington DC office. She served as General Counsel of the Regional Medical Center at Memphis for ten years until 1996 and served as interim General Counsel for the District of Columbia Health and Hospitals Public Benefit Corporation in 1998. In 1993, Ms. Collins co-founded a managed care plan and served on its board of directors through 1996. She has also served on the boards of two primary care centers, a Medicare Part A intermediary company, and as a leadership coach for the Robert Wood Johnson Foundation’s Health Policy Fellows program. In 2006, Modern Healthcare magazine named her one of the top 25 most influential minority healthcare executives.

Samuel Frieder

Mr. Samuel P. Frieder is an Independent Director of BioScrip Inc. He was appointed a director of the Company in connection with the Company’s acquisition of CHS in March 2010. Mr. Frieder is the Managing Partner of Kohlberg & Co., L.L.C. (“Kohlberg”) and a member of Kohlberg’s Investment Committee. Mr. Frieder joined Kohlberg in 1989, became a principal in 1995 and named Managing Partner in 2006. He is a member of the board of directors of Aurora Products Group, LLC, Bauer Performance Sports, Ltd, Chronos Life Group, LP, e+CancerCare, LLC, HawkeyePedershaab, Inc., Katy Industries, Inc., Kellermeyer Bergensons Services, LLC, Nellson Nutraceutical, LLC, Nielsen & Bainbridge, LLC, Packaging Dynamics Corporation, Pittsburgh Glass Works, LLC, Phillips-Medisize Corporation, Risk Strategies Company, Sabre Industries, Inc., SouthernCare, Inc., Stanadyne Corporation, SVP Holdings, Ltd. and Trico Products Corp. Mr. Frieder received an A.B. from Harvard College.

David Hubers

Mr. David R. Hubers is an Independent Director of BioScrip Inc. since March 2005. Prior to being appointed a director of the Company he had served as a director of Chronimed since November 2000. Mr. Hubers was Chairman of American Express Financial Advisors, Inc. prior to his retirement. He joined American Express Financial Advisors Inc. in 1965 and held various positions, including Senior Vice President of Finance and Chief Financial Officer until being appointed President and Chief Executive Officer in August 1993. He served in that capacity until June 2001. Mr. Hubers served on the boards of directors of the Carlson School of Management at the University of Minnesota and Lawson Software.

Yon Jorden

Ms. Yon Yoon Jorden is Independent Director of the Company. Ms. Jorden is a National Association of Corporate Directors (NACD) Board Leadership Fellow and currently serves on the board of directors of Methodist Health System, a Texas-based not-for-profit hospital system, and Maxwell Technologies, Inc., a publicly-traded manufacturer of energy storage and power delivery solutions. She previously served on the board of directors of Magnetek, Inc. and U.S. Oncology.

Huong Thi Nguyen

Dr. Huong Thi Nguyen, M.D., is Independent Director of BioScrip Inc. Dr. Nguyen is an industry veteran with more than 20 years of leadership experience in managed care and health insurance. She currently serves as the president of Texas Health Population Health, Education, Research and Innovation Center, an organization devoted to sharing best practices, disseminating information about innovative approaches, leading physician-directed population health initiatives and coordinating community-based well-being collaboration. Until September 2013, Dr. Nguyen served as the Chief Medical Officer of Banner Health Network, where she oversaw the activities of more than 2,500 physicians. Between 2008 and 2011 she held senior positions at Blue Cross Blue Shield in Kansas City and Florida. From August 2005 to April 2008, Dr. Nguyen was Vice President and Market Medical Officer of Humana, Inc., a managed health care company that markets and administers health insurance. Dr. Nguyen received her medical degree from the University of Missouri’s Columbia School of Medicine and her Bachelors of Science from Creighton University School of Pharmacy. She also holds a Medical Management Executive MBA from the University of Texas at Dallas.

Stuart Samuels

Dr. Stuart A. Samuels is an Independent Director of BioScrip Inc. since March 2005. Prior to being appointed a director of the Company he had served as a director of Chronimed since November 2000. Since 1990, Mr. Samuels has been a management consultant, specializing in business management, strategic sales and marketing and business development for several companies, specifically in the pharmaceutical and healthcare industries. Mr. Samuels served on the board of directors of Target Rx, Inc. from 2000-2011, and the board of Infomedics, Inc. from 2005-2012.

Gordon Woodward

Mr. Gordon H. Woodward is an Independent Director of BioScrip Inc. Mr. Woodward is a Partner and Chief Investment Officer of Kohlberg and a member of Kohlberg’s Investment Committee. Mr. Woodward joined Kohlberg in 1996, became a Partner in 2001 and Chief Investment Officer in 2010. He is a member of the board of directors of Aurora Products Group, LLC, Bauer Performance Sports, Ltd., Chronos Life Group, LP, e+CancerCare, LLC, Kellermeyer Bergensons Services, LLC, Nellson Nutraceutical, LLC, Nielsen & Bainbridge, LLC, Packaging Dynamics Corporation, Pittsburgh Glass Works, LLC, Phillips-Medisize Corporation, Risk Strategies Company, Sabre Industries, Inc., SouthernCare, Inc., Stanadyne Corporation , SP Plus Corp. and SVP Holdings Ltd. Prior to joining Kohlberg, Mr. Woodward was with James D. Wolfensohn Incorporated. Mr. Woodward received an A.B. from Harvard College.

Lisa Carlton-Wilson

Search Stocks